Head-to-head · Value Score
Gimme Care vs Levers Health
Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, Levers Health a 75. Here's who gives you the honest lower price — and where each one bites back.
Gimme Care
#5 · Grade A · Best Value
Est. first month
$130/mo
Save ~90% vs brand-nameLevers Health
#130 · Grade C+ · Fair Price
Est. first month
From $123/mo (compounded)
Save ~91% vs brand-nameThe verdict
Gimme Care takes it on Value Score, 91 to 75 — an est. $130/mo first month, with no teaser step-up baked in. Levers Health isn't out of it: Patients interested in GLP-1 microdosing for longevity.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Gimme Care | Levers Health |
|---|---|---|
| Value Score | 91 (A) | 75 (C+) |
| Est. first month | $130/mo | From $123/mo (compounded) |
| Save vs brand-name | ~90% | ~91% |
| Semaglutide | $130/mo | From $123/mo (compounded) |
| Tirzepatide | $163/mo | From $296/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Gimme Care
Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.
Why it's a deal
- Low flat price on both molecules ($130 sema / $163 tirz)
- LegitScript-certified pharmacy
- Available in all 50 states
The fine print
- No brand-name option — compounded only
- No oral/sublingual form
Levers Health
Levers Health (Levers Health LLC) offers compounded semaglutide (from $247/mo) and tirzepatide (from $296/mo), plus low-dose/microdose GLP-1 for longevity.
Why it's a deal
- Named LLC entity
- Microdose GLP-1 option marketed for longevity
- Both semaglutide and tirzepatide available
The fine print
- No LegitScript or PCAB accreditation
- No physical address disclosed
- State availability not disclosed
- FAQ and terms pages return 404
- Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to Levers Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.